Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Advances in Therapy|February 23, 2011
The once-daily human glucagon-like peptide-1 (GLP-1) analog liraglutide improves postprandial glucose levels in type 2 diabetes patientsAnne Flint, Christoph Kapitza, Charlotte Hindsberger, et al.
Advances in Therapy|July 28, 2011
The effect of the once-daily human glucagon-like peptide 1 analog liraglutide on the pharmacokinetics of acetaminophenChristoph Kapitza, Milan Zdravkovic, Charlotte Hindsberger, et al.
The American Journal of Clinical Nutrition|October 7, 2006
Glycemic index and glycemic load in relation to changes in body weight, body fat distribution, and body composition in adult DanesHelle Hare-Bruun, Anne Flint, Berit L Heitmann
Ugeskrift for Laeger|January 13, 2006
[Prevention of obesity]Thomas Meinert Larsen, Anne Flint, Berit Lilienthal Heitmann
International Journal of Sport Nutrition and Exercise Metabolism|August 11, 2005
Dietary supplement use by varsity athletes at a Canadian universityMartin Kristiansen, Ryna Levy-Milne, Susan Barr, et al.
Obesity Research|December 25, 2003
Effects of different dietary fat types on postprandial appetite and energy expenditureAnne Flint, Berit Helt, Anne Raben, et al.
British Journal of Clinical Pharmacology|December 24, 2010
Influence of hepatic impairment on pharmacokinetics of the human GLP-1 analogue, liraglutideAnne Flint, Khalil Nazzal, Pawel Jagielski, et al.
The Proceedings of the Nutrition Society|July 23, 2002
Low-fat diets and energy balance: how does the evidence stand in 2002?Arne Astrup, Arne Astrup, Benjamin Buemann, et al.
Clinical Pharmacokinetics|November 25, 2015
Liraglutide in Type 2 Diabetes Mellitus: Clinical Pharmacokinetics and PharmacodynamicsLisbeth V Jacobsen, Anne Flint, Anette K Olsen, et al.
Pageof 5